CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation

There are still no effective diagnostic and prognostic biomarkers in pancreatic ductal adenocarcinoma (PDAC). The differentiation between PDAC and chronic pancreatitis (CP) is often challenging. The inflammatory mass in the course of CP causes diagnostic difficulties in differentiating them from neo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical medicine 2023-06, Vol.12 (12), p.4050
Hauptverfasser:	Wlodarczyk, Barbara, Durko, Lukasz, Wlodarczyk, Przemyslaw, Talar-Wojnarowska, Renata, Malecka-Wojciesko, Ewa
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Asymptomatic Bile ducts Bioavailability Biomarkers Clinical medicine Diabetes Endocrine disorders Extracellular matrix Fibroblasts Hyperglycemia Insulin resistance Insulin-like growth factors Ligands Medical prognosis Pancreatic cancer Pancreatitis Proteins Thyroid gland
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!